ProQR (PRQR) director Hinsch Gylvin Lykke files Form 3 with no share activity

Rhea-AI Filing Summary

ProQR Therapeutics N.V. director Hinsch Gylvin Lykke filed an initial Form 3 as an insider of the company. The data provided shows no reported transactions, no derivative positions, and no holding entries, so this filing mainly establishes insider status without disclosing any ownership changes.

Key Figures

Net insider share change: 0 shares Buy transactions: 0 Sell transactions: 0 +1 more

4 metrics

Net insider share change 0 shares Form 3 transactionSummary netBuySellShares

Buy transactions 0 Form 3 transactionSummary buyCount

Sell transactions 0 Form 3 transactionSummary sellCount

Derivative positions 0 Form 3 derivativeTransactionCount and empty derivativeSummary

Key Terms

Form 3, reporting person, ten percent owner

3 terms

Form 3 regulatory

"Form 3 filing shows that Hinsch Gylvin Lykke is a director"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"The Form 3 data lists Hinsch Gylvin Lykke as a reporting person"

ten percent owner financial

"The ten_percent_owner flag for Hinsch Gylvin Lykke is set to 0"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hinsch Gylvin Lykke

(Last) (First) (Middle)

PROQR THERAPEUTICS N.V.

ZERNIKEDREEF 9

(Street)

LEIDEN 2333 CK

(City) (State) (Zip)

NETHERLANDS

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/02/2026

3. Issuer Name and Ticker or Trading Symbol
ProQR Therapeutics N.V. [ PRQR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Pieter Erik de Ridders, Attorney-in-Fact	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the ProQR (PRQR) Form 3 filing by Hinsch Gylvin Lykke show?

The Form 3 filing shows that Hinsch Gylvin Lykke is a director at ProQR Therapeutics N.V. It reports no transactions, no derivative positions, and no holding entries, serving mainly to establish insider status with the SEC for disclosure purposes.

Did Hinsch Gylvin Lykke buy or sell any PRQR shares in this Form 3?

No, the Form 3 indicates zero buy, sell, acquire, or dispose transactions for PRQR shares. Transaction counts and net share changes are all reported as zero, meaning no trading activity is disclosed in this filing.

Does this ProQR (PRQR) Form 3 include any stock options or derivatives?

No, the derivative summary in the Form 3 is empty, and derivativeTransactionCount and exerciseCount are both zero. This indicates no stock options, warrants, or other derivative positions are reported for Hinsch Gylvin Lykke in this filing.

Is Hinsch Gylvin Lykke a ten percent owner of ProQR (PRQR) according to this Form 3?

According to the Form 3 data, the ten_percent_owner flag for Hinsch Gylvin Lykke is set to 0. This means the individual is reported as a director but not as a beneficial owner of ten percent or more of ProQR’s outstanding shares.

Does the ProQR (PRQR) Form 3 report any gifts or tax-related share withholdings?

No, the transaction summary shows giftCount and taxWithholdingCount as zero, with corresponding share amounts also zero. This indicates the filing reports no gifts of shares and no shares withheld for tax obligations related to equity awards.